Navigation Links
Special Session Highlights Late-Breaking Abstracts

Range of gynecologic oncology research is as impressive as pace

CHICAGO, March 8 /PRNewswire-USNewswire/ -- In their continuing quest to eradicate women's cancer, gynecologic oncologists are developing new approaches to treatment, diagnosis and prevention of these diseases. An outstanding assortment of new research—covering everything from advances in chemotherapy (such as intraperitoneal therapy) and cancer screening, to surgical methods that improve quality of life and preventive practices that stop dangerous precursors from turning into cancer—will be on display in San Francisco March 14-17, 2010, during the Society of Gynecologic Oncologists' 41st Annual Meeting on Women's Cancer, the premier scientific meeting for women's cancer specialists.

Two new randomized clinical trials and one new post-hoc analysis, among others, offer the latest evidence of the specialty's commitment to improving treatment and prevention of disease. The abstracts will be presented on March 15 during the Late Breaking Abstracts (LBA) session at the Annual Meeting. Five late-breaking abstracts were selected for the session, and three are being highlighted as representative of the specialty's range of research.

"These abstracts are indicative of the high-quality research being conducted in our sub-specialties," said Dr. David G. Mutch, president of the SGO. "It is very encouraging to see the frequency with which important results are becoming available and we are thrilled to be able to showcase these studies at our Annual Meeting, where our colleagues from across the country and the world can evaluate the findings and learn about the latest approaches."

SGO 41st Annual Meeting on Women's Cancer

The SGO LBA session highlights significant research completed after the Annual Meeting's usual abstract submission deadline. The abstracts selected for this year's LBA session are scheduled to be published in the May 2010 issue of Gynecologic Oncology.

The clinical trials featured in the LBA session indicate that laparoscopic surgery for uterine cancer offers several quality-of-life advantages (less pain and surgical recovery time, higher ratings on FACT-G and other quality-of-life evaluations) over full abdominal incisional procedures for hysterectomy—and is just as safe and effective. The post-hoc analysis featured in the session indicates that HPV vaccine reduces recurrence of HPV-related cervical, vulvar and vaginal lesions after definitive surgery for those diseases.

"We selected this year's late-breaking abstracts from an outstanding pool of submissions completed between December of last year and this February," said Dr. Thomas Herzog, chairman of the program committee for SGO's 2010 Annual Meeting. "The range of late-breaking submissions shows the level of commitment within the specialty not just to surgical advances, but to staging, diagnostics, quality of life and prevention."

Featured Late Breaking Abstracts 2010

The following late-breaking abstracts are being highlighted during the LBA session, March 15:

  • Recurrence and Survival after Randomization to Laparoscopy versus Laparotomy for Comprehensive Surgical Staging of Uterine Cancer (Gynecologic Oncology Group LAP2) Joan Walker, MD
  • Improved Short-term and Long-term Quality of Life for Patients with Endometrial Cancer: Quality of Life Results from the LACE Randomized Controlled Trial Comparing Total Laparoscopic Hysterectomy versus Total Abdominal Hysterectomy for Stage I Endometrial CancerAndreas Obermair
  • Impact of the Quadrivalent HPV6/11/16/18 Vaccine in Women Who have Undergone Definitive Therapy: Do These Women Benefit from Vaccination? Warner Huh, MD

About SGO

The SGO is a national medical specialty organization of physicians who are trained in the comprehensive management of women with malignancies of the reproductive tract. Its purpose is to improve the care of women with gynecologic cancer by encouraging research, disseminating knowledge, which will raise the standards of practice in the prevention and treatment of gynecologic malignancies, and cooperating with other organizations interested in women's health care, oncology and related fields. The Society's membership, totaling more than 1230, is primarily comprised of gynecologic oncologists, as well as other related medical specialists including medical oncologists, radiation oncologists and pathologists. SGO members provide multidisciplinary cancer treatment including chemotherapy, radiation therapy, surgery and supportive care. More information on the SGO can be found at

SOURCE Society of Gynecologic Oncologists

Back to top



SOURCE Society of Gynecologic Oncologists
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
2. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
3. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
6. Mercedes-Benz Special Edition C350 Sport Sedan to Raise $1 Million for Saks Fifth Avenues KEY TO THE CURE
7. Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
8. Uninsured community health center patients often have difficulty accessing specialty services
9. Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer
10. Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation
11. Inspiring Authors Tell Inspirational Stories: Special Writers Find Accepting Home at
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... ... announce the speakers for “Value-Based Payer-Provider Partnerships: Three Case Studies,” an upcoming ... value-based care arrangements: Essentia Health and UCare, MissionPoint Health Partners, and Intel ...
(Date:11/30/2015)... ... November 30, 2015 , ... Insightra ... TIGR® Matrix Surgical Mesh technology for soft tissue repair in the US via ... a long-term resorbable surgical mesh intended to support and reinforce soft tissue for ...
(Date:11/30/2015)... ... , ... GKhair & Tibolli team members and artists were excited and proud ... 8th and 9th at the Puerto Rico Convention Center, San Juan Puerto Rico. The ... of the line fashion journalists. The San Juan Beauty Show carries immense credibility among ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... to announce their strategic partnership at the Radiological Society of North America ... and Winscribe, global providers of cutting-edge dictation and speech-enabled documentation software, announced ...
(Date:11/30/2015)... Miami, FL (PRWEB) , ... November 30, 2015 ... ... manufacturer and engineer of patented products, announces the Unstoppable Swappables, a household invention ... Window Coverings Industry makes $2 billion a year and is growing at 2.6%," ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... November 30, 2015 Elbit Imaging ... "Company") announced today that it was informed by InSightec Ltd. ... Safety (MFDS) has approved its Exablate Neuro system to ... --> --> Insightec,s Exablate Neuro platform ... that combines two technologies: Focused Ultrasound, which is used ...
(Date:11/29/2015)... Nov. 29, 2015  The GE Health Cloud 1 ... Society of North America (RSNA) meeting ... healthcare industry, the new cloud ecosystem and its applications will ... care pathways and multidisciplinary teams – both inside and outside ... and CEO of GE. "As the digital industrial leader, we ...
(Date:11/27/2015)... Niederlande, November 27, 2015 ... bei fortgeschrittenem Krebs.   --> Ein ... fortgeschrittenem Krebs.   --> Ein ... fortgeschrittenem Krebs.   Clinical Cancer Research ... Clinical Cancer Research vom 6. November ...
Breaking Medicine Technology: